Post by
ISAloser247 on Jan 24, 2010 10:44am
Re: old news releases
Not only a good article, but a GREAT article, IF YOU ARE A LUX STAKEHOLDER! Did YOU notice thru Your rose-coloured glasses that there was NO MENTION OF ISOTECHNIKA!
By their very nature, new releases are DATED and TIME-SENSITIVE, reflecting information that is current, or
EXPECTATIONS that are "BELIEVED TO BE REASONABLE" at the time of issuance. Reading out -of-date news releases can, therefore be MISLEADING and should never be relied upon as a current statement of fact or expectation!
Comment by
go4future on Jan 25, 2010 10:43am
Lets stick to the facts.... I'd say Lux Biosciences has considerable future expectations and investments at stake with their Isotechnika relationship considering that virtually all of their future pipeline LX211 (Luveniq), LX12, LX13 & LX14 involves Voclosporin.
https://www.luxbio.com/pipeline.htm